Pharmafile Logo
Pharmafocus logo
Advanced Search

Health and Social Care Bill

Showing 6 posts of 21 posts found.

Lib Dems push for major amendments in Health Bill

March 14, 2011
Dr Even Harris, Health and Social Care Bill, Liberal Democrat health policy, NHS, NHS reforms

Liberal Democrats activists have rejected the government’s NHS reform programme, voting overwhelmingly in favour of a major amendment to the …

News

Market forces won’t produce needed restructure, warns King’s Fund

March 4, 2011
GP consortia, Health and Social Care Bill, Kings Fund, NHS, NHS Commissioning Board, NHS reforms, foundation trusts, hospital trusts, king's fund

Greater competition in the NHS is unlikely to bring about the restructuring needed in hospital services, according to The King’s …

News

NHS competition plans provide focus for dissent

March 3, 2011
Health and Social Care Bill, NHS, NHS reforms

Confusion and controversy surround the government plans to introduce greater levels of competition into the NHS, with many stakeholder groups …

Feature

Commissioning Board to spearhead NHS reforms

February 23, 2011
GP consortia, Health and Social Care Bill, NHS, NHS Commissioning Board, NHS reforms, PCT clusters, PCTs, SHAs, Sir David Nicholson, pathfinder consortia

NHS chief executive Sir David Nicholson says the new NHS Commissioning Board will be the driving force behind the health …

News

Value-based pricing will not harm industry, says NICE chief

February 18, 2011
Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing

NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …

News

Alliance concerned over NHS competition reforms

February 10, 2011
Health and Social Care Bill, NHS, NHS Alliance, NHS reforms

The NHS Alliance has called on the Government to clarify major issues around the Health and Social Care Bill which …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026